CD8+ T cell; cancer-associated fibroblast; prognostic biomarker; predictive biomarker; immunotherapy
EGFR-mutant, early-stage NSCLC, (neo)adjuvant targeted therapy, Neoadjuvant immunotherapy, ctDNA
Non-small lung cancer, Leptomeningeal metastasis, Deep learning-driven diagnosis, Visual attention